The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Iron Overload in Human Disease
Abstract
Iron is both essential and toxic. The authors review how the body absorbs, uses, and loses iron and explore both common and unusual causes of iron overload and treatment of the resulting disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Decoupling Ferritin Synthesis from Free Cytosolic Iron Results in Ferritin Secretion
Domenico, I. D., Vaughn, M. B., Paradkar, P. N., Lo, E., Ward, D. M., & Kaplan, J. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2010.12.003 · Cited by 31
RetractedHepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
The ferritins: molecular properties, iron storage function and cellular regulation
Harrison, P. M., & Arosio, P. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(96)00022-9 · Cited by 2,667
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026
Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis
Papanikolaou, G., Samuels, M. E., Ludwig, E. H., MacDonald, M. L. E., Franchini, P. L., Dubé, M.-P., Andres, L., MacFarlane, J., Sakellaropoulos, N., Politou, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1274 · Cited by 974
Serum ferritin: Past, present and future
Wang, W., Knovich, M. A., Coffman, L. G., Torti, F. M., & Torti, S. V. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.03.011 · Cited by 879
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C. (2003) · Nature Genetics · doi:10.1038/ng1053 · Cited by 860
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., et al. (2007) · Nature Medicine · doi:10.1038/nm1629 · Cited by 854
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
Camaschella, C., Roetto, A., Calì, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A., & Gasparini, P. (2000) · Nature Genetics · doi:10.1038/75534 · Cited by 803
BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
Andriopoulos Jr, B., Corradini, E., Xia, Y., Faasse, S. A., Chen, S., Grgurevic, L., Knutson, M. D., Pietrangelo, A., Vukicevic, S., Lin, H. Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.335 · Cited by 769
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome
Zhou, B., Westaway, S. K., Levinson, B., Johnson, M. A., Gitschier, J., & Hayflick, S. J. (2001) · Nature Genetics · doi:10.1038/ng572 · Cited by 752
Puccio, H., Simon, D., Cossée, M., Criqui-Filipe, P., Tiziano, F., Melki, J., Hindelang, C., Matyas, R., Rustin, P., & Koenig, M. (2001) · Nature Genetics · doi:10.1038/84818 · Cited by 738
Genetic, Clinical, and Radiographic Delineation of Hallervorden–Spatz Syndrome
Hayflick, S. J., Westaway, S. K., Levinson, B., Zhou, B., Johnson, M. A., Ching, K. H. L., & Gitschier, J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020817 · Cited by 714
Metals in Alzheimer's and Parkinson's Diseases
Barnham, K. J., & Bush, A. I. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.02.019 · Cited by 695
Non-transferrin bound iron: a key role in iron overload and iron toxicity
Brissot, P., Ropert, M., Le Lan, C., & Loréal, O. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.07.014 · Cited by 654
Knovich, M. A., Storey, J. A., Coffman, L. G., Torti, S. V., & Torti, F. M. (2009) · Blood Reviews · doi:10.1016/j.blre.2008.08.001 · Cited by 627
A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614
Lack of the bone morphogenetic protein BMP6 induces massive iron overload
Meynard, D., Kautz, L., Darnaud, V., Canonne-Hergaux, F., Coppin, H., & Roth, M.-P. (2009) · Nature Genetics · doi:10.1038/ng.320 · Cited by 587
Silvestri, L., Pagani, A., Nai, A., De Domenico, I., Kaplan, J., & Camaschella, C. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.012 · Cited by 555
Ponka, P. (1997) · Blood · doi:10.1182/blood.v89.1.1 · Cited by 552
Self-citationCurtis, A. R. J., Fey, C., Morris, C. M., Bindoff, L. A., Ince, P. G., Chinnery, P. F., Coulthard, A., Jackson, M. J., Jackson, A. P., McHale, D. P., et al. (2001) · Nature Genetics · doi:10.1038/ng571 · Cited by 537
Richardson, D. R., Lane, D. J. R., Becker, E. M., Huang, M. L.-H., Whitnall, M., Rahmanto, Y. S., Sheftel, A. D., & Ponka, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912925107 · Cited by 536
Self-citationHIF-2α, but not HIF-1α, promotes iron absorption in mice
Mastrogiannaki, M., Matak, P., Keith, B., Simon, M. C., Vaulont, S., & Peyssonnaux, C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38499 · Cited by 502
Knutson, M. D., Oukka, M., Koss, L. M., Aydemir, F., & Wessling-Resnick, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409409102 · Cited by 479
Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance
Babitt, J. L., Huang, F. W., Xia, Y., Sidis, Y., Andrews, N. C., & Lin, H. Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31342 · Cited by 457
Hepcidin in iron overload disorders
Papanikolaou, G., Tzilianos, M., Christakis, J. I., Bogdanos, D., Tsimirika, K., MacFarlane, J., Goldberg, Y. P., Sakellaropoulos, N., Ganz, T., & Nemeth, E. (2005) · Blood · doi:10.1182/blood-2004-12-4844 · Cited by 445
Kautz, L., Meynard, D., Monnier, A., Darnaud, V., Bouvet, R., Wang, R.-H., Deng, C., Vaulont, S., Mosser, J., Coppin, H., et al. (2008) · Blood · doi:10.1182/blood-2008-03-143354 · Cited by 437
Shah, Y. M., Matsubara, T., Ito, S., Yim, S.-H., & Gonzalez, F. J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.12.012 · Cited by 431
Iron uptake and metabolism in the new millennium
Dunn, L. L., Rahmanto, Y. S., & Richardson, D. R. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.12.003 · Cited by 420
Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload
Niederkofler, V. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25683 · Cited by 372
Iron-Chelating Therapy for Transfusional Iron Overload
Brittenham, G. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmct1004810 · Cited by 366
A mouse model of juvenile hemochromatosis
Huang, F. W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25049 · Cited by 365
Goswami, T., & Andrews, N. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600197200 · Cited by 352
Tanno, T., Porayette, P., Sripichai, O., Noh, S.-J., Byrnes, C., Bhupatiraju, A., Lee, Y. T., Goodnough, J. B., Harandi, O., Ganz, T., et al. (2009) · Blood · doi:10.1182/blood-2008-12-195503 · Cited by 352
The Transferrin Receptor Modulates Hfe-Dependent Regulation of Hepcidin Expression
Schmidt, P. J., Toran, P. T., Giannetti, A. M., Bjorkman, P. J., & Andrews, N. C. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.016 · Cited by 345
Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor
Bennett, M. J., Lebrón, J. A., & Bjorkman, P. J. (2000) · Nature · doi:10.1038/47417 · Cited by 337
Gao, J., Chen, J., Kramer, M., Tsukamoto, H., Zhang, A.-S., & Enns, C. A. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.010 · Cited by 326
Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis
Silvestri, L., Pagani, A., & Camaschella, C. (2008) · Blood · doi:10.1182/blood-2007-07-100677 · Cited by 311
Rivera, S., Nemeth, E., Gabayan, V., Lopez, M. A., Farshidi, D., & Ganz, T. (2005) · Blood · doi:10.1182/blood-2005-04-1766 · Cited by 308
Iron-regulatory proteins limit hypoxia-inducible factor-2α expression in iron deficiency
Sanchez, M., Galy, B., Muckenthaler, M. U., & Hentze, M. W. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1222 · Cited by 294
LPI-labile plasma iron in iron overload
CABANTCHIK, Z., BREUER, W., ZANNINELLI, G., & CIANCIULLI, P. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.10.003 · Cited by 293
Zhang, D.-L., Hughes, R. M., Ollivierre-Wilson, H., Ghosh, M. C., & Rouault, T. A. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.006 · Cited by 281
Rouault, T. A., & Cooperman, S. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.08.002 · Cited by 280
Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis
Harris, Z., Klomp, L., & Gitlin, J. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.5.972s · Cited by 256
New mutations inactivating transferrin receptor 2 in hemochromatosis type 3
Roetto, A., Totaro, A., Piperno, A., Piga, A., Longo, F., Garozzo, G., Calı̀, A., De Gobbi, M., Gasparini, P., & Camaschella, C. (2001) · Blood · doi:10.1182/blood.v97.9.2555 · Cited by 247
Hepcidin in Human Iron Disorders: Diagnostic Implications
Kroot, J. J., Tjalsma, H., Fleming, R. E., & Swinkels, D. W. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2009.140053 · Cited by 246
Self-citationXia, Y., Babitt, J. L., Sidis, Y., Chung, R. T., & Lin, H. Y. (2008) · Blood · doi:10.1182/blood-2007-09-111567 · Cited by 222
Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice
Gardenghi, S., Ramos, P., Marongiu, M. F., Melchiori, L., Breda, L., Guy, E., Muirhead, K., Rao, N., Roy, C. N., Andrews, N. C., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41717 · Cited by 220
HFE Genotype in Patients with Hemochromatosis and Other Liver Diseases
Bacon, B. R., Olynyk, J. K., Brunt, E. M., Britton, R. S., & Wolff, R. K. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-12-199906150-00002 · Cited by 214
Kato, J., Fujikawa, K., Kanda, M., Fukuda, N., Sasaki, K., Takayama, T., Kobune, M., Takada, K., Takimoto, R., Hamada, H., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/321261 · Cited by 211
Wallace, D. F., Summerville, L., Crampton, E. M., Frazer, D. M., Anderson, G. J., & Subramaniam, V. N. (2009) · Hepatology · doi:10.1002/hep.23198 · Cited by 209
Optimal management of β thalassaemia intermedia
Taher, A. T., Musallam, K. M., Cappellini, M. D., & Weatherall, D. J. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08486.x · Cited by 207
High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis
Whitington, P. F., & Hibbard, J. U. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17356-x · Cited by 200
Galy, B., Ferring-Appel, D., Kaden, S., Gröne, H.-J., & Hentze, M. W. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.006 · Cited by 195
Transferrin therapy ameliorates disease in β-thalassemic mice
Li, H., Rybicki, A. C., Suzuka, S. M., von Bonsdorff, L., Breuer, W., Hall, C. B., Cabantchik, Z. I., Bouhassira, E. E., Fabry, M. E., & Ginzburg, Y. Z. (2010) · Nature Medicine · doi:10.1038/nm.2073 · Cited by 192
Zimmer, M., Ebert, B. L., Neil, C., Brenner, K., Papaioannou, I., Melas, A., Tolliday, N., Lamb, J., Pantopoulos, K., Golub, T., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.12.004 · Cited by 191
Pathogenesis and management of iron toxicity in thalassemia
Hershko, C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05544.x · Cited by 176
The molecular basis of hepcidin-resistant hereditary hemochromatosis
Fernandes, A., Preza, G. C., Phung, Y., De Domenico, I., Kaplan, J., Ganz, T., & Nemeth, E. (2009) · Blood · doi:10.1182/blood-2008-03-146134 · Cited by 167
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis
Corradini, E., Garuti, C., Montosi, G., Ventura, P., Andriopoulos, B., Lin, H. Y.-F., Pietrangelo, A., & Babitt, J. L. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.057 · Cited by 156
Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes
Pietrangelo, A., Caleffi, A., Henrion, J., Ferrara, F., Corradini, E., Kulaksiz, H., Stremmel, W., Andreoné, P., & Garuti, C. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.057 · Cited by 151
Thomas, M., Hayflick, S. J., & Jankovic, J. J. (2004) · Movement Disorders · doi:10.1002/mds.10650 · Cited by 151
Domenico, I. D., Lo, E., Ward, D. M., & Kaplan, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900453106 · Cited by 147
Tamary, H., Shalev, H., Perez-Avraham, G., Zoldan, M., Levi, I., Swinkels, D. W., Tanno, T., & Miller, J. L. (2008) · Blood · doi:10.1182/blood-2008-06-165738 · Cited by 135
Iron metabolism in the erythrophagocytosing Kupffer cell
Kondo, H. G., Saito, K., Grasso, J. P., & Aisen, P. (1988) · Hepatology · doi:10.1002/hep.1840080108 · Cited by 133
HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity # †
Gurrin, L. C., Bertalli, N. A., Dalton, G. W., Osborne, N. J., Constantine, C. C., McLaren, C. E., English, D. R., Gertig, D. M., Delatycki, M. B., Nicoll, A., et al. (2009) · Hepatology · doi:10.1002/hep.22972 · Cited by 131
Neonatal Hemochromatosis: A Congenital Alloimmune Hepatitis
Whitington, P. F. (2007) · Seminars in Liver Disease · doi:10.1055/s-2007-985069 · Cited by 130
McLaren, C. E., Barton, J. C., Adams, P. C., Harris, E. L., Acton, R. T., Press, N. A., Reboussin, D. M., McLaren, G. D., Sholinsky, P. D., Walker, A. P., et al. (2003) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200302000-00001 · Cited by 130
Hepcidin in human iron disorders: Therapeutic implications
Pietrangelo, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.004 · Cited by 126
Hepcidin and iron-loading anemias.
Nemeth, E., & Ganz, T. (2006) · PubMed · Cited by 124
Regulation of Type II Transmembrane Serine Proteinase TMPRSS6 by Hypoxia-inducible Factors
Lakhal‐Littleton, S., Schödel, J., Townsend, A., Pugh, C. W., Ratcliffe, P. J., & Mole, D. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.173096 · Cited by 119
BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression
Kautz, L., Meynard, D., Besson‐Fournier, C., Darnaud, V., Saati, T. A., Coppin, H., & Roth, M. (2009) · Blood · doi:10.1182/blood-2009-02-206771 · Cited by 118
Childhood disorders of neurodegeneration with brain iron accumulation (NBIA)
Kurian, M. A., McNeill, A., Lin, J., & Maher, E. R. (2011) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2011.03955.x · Cited by 110
Diagnosis and management of hereditary haemochromatosis
van Bokhoven, M. A., van Deursen, C. T. B. M., & Swinkels, D. W. (2011) · BMJ · doi:10.1136/bmj.c7251 · Cited by 105
Poli, M., Luscieti, S., Gandini, V., Maccarinelli, F., Finazzi, D., Silvestri, L., Roetto, A., & Arosio, P. (2010) · Haematologica · doi:10.3324/haematol.2010.027003 · Cited by 93
The genetics of inherited sideroblastic anemias
Fleming, M. D. (2002) · Seminars in Hematology · doi:10.1053/shem.2002.35637 · Cited by 87
Chen, J., Chloupková, M., Gao, J., Arvedson, T., & Enns, C. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706720200 · Cited by 86
Murray, K. F., & Kowdley, K. V. (2001) · PEDIATRICS · doi:10.1542/peds.108.4.960 · Cited by 86
Iron Homeostasis and Its Interaction with Prolyl Hydroxylases
Mole, D. R. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2790 · Cited by 85
Alteration in Cobalt Absorption in Patients with Disorders of Iron Metabolism
VALBERG, L. S., Ludwig, J., & Olatunbosun, D. A. (1969) · Gastroenterology · doi:10.1016/s0016-5085(69)80123-x · Cited by 85
Iron overload due to mutations in ferroportin.
Domenico, I. D., Ward, D. M., Musci, G., & Kaplan, J. (2006) · PubMed · Cited by 84
Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice
Bartnikas, T. B., Andrews, N. C., & Fleming, M. D. (2011) · Blood · doi:10.1182/blood-2010-05-287359 · Cited by 77
Iron Overload: Consequences, Assessment, and Monitoring
Taher, A. T., Musallam, K. M., & Inati, A. C. (2009) · Hemoglobin · doi:10.3109/03630260903346676 · Cited by 76
Frataxin: its role in iron metabolism and the pathogenesis of Friedreich's ataxia
Becker, E., & Richardson, D. R. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(00)00067-4 · Cited by 71
Towards explaining "unexplained hyperferritinemia"
Camaschella, C., & Poggiali, E. (2009) · Haematologica · doi:10.3324/haematol.2008.005405 · Cited by 67
Not all DMT1 mutations lead to iron overload
Blanco, E., Kannengiesser, C., Grandchamp, B., Tasso, M., & Beaumont, C. (2009) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2009.05.003 · Cited by 56
Ferroportin (Q248H) mutations in African families with dietary iron overload
McNamara, L., Gordeuk, V. R., & MacPhail, A. P. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03930.x · Cited by 54
The Congenital Dyserythropoietic Anemias
Renella, R., & Wood, W. G. (2009) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.01.010 · Cited by 51
Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia
Trombini, P., Coliva, T. A., Nemeth, E., Mariani, R., Ganz, T., Biondi, A., & Piperno, A. (2007) · Haematologica · doi:10.3324/haematol.11377 · Cited by 51
Regulation of Intestinal Iron Absorption: The Mucosa Takes Control?
Simpson, R. J., & McKie, A. T. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.06.009 · Cited by 49
Blood lead concentrations in hereditary hemochromatosis.
Barton, J. C., Ma, P., Cq, E., Griffen, L. M., Kushner, J. P., Rg, M., & Rw, L. (1994) · PubMed · Cited by 48
Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II
Casanovas, G., Swinkels, D. W., Altamura, S., Schwarz, K., Laarakkers, C. M., Gross, H.-J., Wiesneth, M., Heimpel, H., & Muckenthaler, M. U. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0751-5 · Cited by 47
Iron overload in myelodysplastic syndromes
Mahesh, S. A., Ginzburg, Y. Z., & Verma, A. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190701843221 · Cited by 40
Biochemical and genetic defects underlying human congenital hypotransferrinemia
Goldwurm, S., Casati, C., Venturi, N., Strada, S., Santambrogio, P., Indraccolo, S., Arosio, P., Cazzola, M., Piperno, A., Masera, G., et al. (2000) · The Hematology Journal · doi:10.1038/sj.thj.6200063 · Cited by 30
Liver Manganese in Hemochromatosis
Altstatt, L. B., Pollack, S., Feldman, M. H., Reba, R. C., & Crosby, W. H. (1967) · Experimental Biology and Medicine · doi:10.3181/00379727-124-31741 · Cited by 20
Breda, L., Gardenghi, S., Guy, E. C., Rachmilewitz, E. A., Weizer‐Stern, O., Adamsky, K., Amariglio, N., Rechavi, G., Giardina, P. J., Grady, R. W., et al. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.069 · Cited by 19
Prospects for a hepcidin mimic to treat β-thalassemia and hemochromatosis
Parrow, N. L., Gardenghi, S., & Rivella, S. (2011) · Expert Review of Hematology · doi:10.1586/ehm.11.22 · Cited by 17
Cited by
The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease
Fang, X., Ardehali, H., Min, J., & Wang, F. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00735-4 · Cited by 1,081
Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis
Fang, X., Cai, Z., Wang, H., Han, D., Cheng, Q., Zhang, P., Gao, F., Yu, Y., Song, Z., Wu, Q., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.316509 · Cited by 770
Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects
Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724
Current understanding of iron homeostasis
Anderson, G. J., & Frazer, D. M. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.155804 · Cited by 688
Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
Devos, D., Moreau, C., Devedjian, J. C., Kluza, J., Petrault, M., Laloux, C., Jonneaux, A., Ryckewaert, G., Garçon, G., Rouaix, N., et al. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5593 · Cited by 619
Metadata
- Authors
- Fleming, R. E., & Ponka, P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-01-26
- Volume
- 366
- Issue
- 4
- Pages
- 348-359
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2328568398
- Cited by
- 587
- References
- 98
- FWCI
- 33.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.